Skip to content

Clinical trials

Completed Phase 1/2 Epstein-Barr Virus Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epstein-Barr Virus Infections Phase: Phase 1/2 Status: Completed Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20072
20081
20121
20142
20151
20161
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)2
University of Minnesota2
AlloVir1
Baylor College of Medicine1
Dr. Jean-Sebastien Delisle, MD, PhD1
GlaxoSmithKline1
Stanford University1
University of Erlangen-Nürnberg Medical School1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epstein-Barr Virus Infections10
Infectious Mononucleosis3
Adenoviridae Infections2
Herpes Simplex2
Virus Diseases2
Cytokine Release Syndrome1
Diabetes Mellitus1
Diabetes Mellitus, Type 11
Fatigue1
Fatigue Syndrome, Chronic1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.